Pages that link to "Q28316780"
Jump to navigation
Jump to search
The following pages link to Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer (Q28316780):
Displaying 50 items.
- Pin1-Targeted Therapy for Systemic Lupus Erythematosus (Q33859906) (← links)
- Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. (Q34108090) (← links)
- Developmental therapeutics in childhood cancer. A perspective from the Children's Oncology Group and the US Food and Drug Administration (Q34417556) (← links)
- Retinoid therapy of childhood cancer. (Q34476968) (← links)
- Retinoid therapy of high-risk neuroblastoma. (Q35184993) (← links)
- Acute promyelocytic leukaemia in children (Q35205514) (← links)
- All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review (Q36021622) (← links)
- The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells (Q36292446) (← links)
- Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice. (Q36613829) (← links)
- A phase 1 study of tazarotene in adults with advanced cancer. (Q36671710) (← links)
- Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas (Q37208463) (← links)
- Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria (Q37267511) (← links)
- Chronic vitamin A status and acute repletion with retinyl palmitate are determinants of the distribution and catabolism of all-trans-retinoic acid in rats (Q37349115) (← links)
- All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats (Q37378345) (← links)
- Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways (Q37681728) (← links)
- Targeted therapy in pediatric and adolescent oncology (Q37869437) (← links)
- A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials (Q38961012) (← links)
- Gene expression and neuroblastoma cell Differentiation in response to retinoic acid: Differential effects of 9-cis and all-trans retinoic acid (Q40423512) (← links)
- Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells (Q40751299) (← links)
- Expression of retinoid receptors during the retinoic acid-induced neuronal differentiation of human embryonal carcinoma cells (Q40873838) (← links)
- Breast cancer therapies in development. A review of their pharmacology and clinical potential. (Q40883320) (← links)
- All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma (Q40883538) (← links)
- Pharmacokinetics of retinoids in women after meal consumption or vitamin A supplementation (Q40928287) (← links)
- Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia (Q40961287) (← links)
- Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid. (Q41056097) (← links)
- Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout (Q41120397) (← links)
- 9-cis retinoic acid--a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma (Q41141096) (← links)
- Pediatric drug development: a perspective from the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). (Q41175743) (← links)
- Phase I trials in paediatric oncology--the European perspective. The New Agents Group of the United Kingdom Childrens Cancer Study Group (Q41175752) (← links)
- The importance of phase I/II trials in pediatric oncology (Q41175764) (← links)
- Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells (Q41331415) (← links)
- Clinical pharmacokinetics of tretinoin (Q41478156) (← links)
- The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin) (Q42548848) (← links)
- Combination therapies improve the anticancer activities of retinoids in neuroblastoma (Q43134812) (← links)
- Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells (Q43773461) (← links)
- Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells (Q44131005) (← links)
- Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia (Q44372826) (← links)
- Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid (Q46515800) (← links)
- Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients (Q46840672) (← links)
- Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions. (Q51105253) (← links)
- All-trans retinoic acid and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma. (Q54025103) (← links)
- Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways. (Q54917620) (← links)
- Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia. (Q54968639) (← links)
- Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells (Q58793896) (← links)
- All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia (Q70998440) (← links)
- Pharmacokinetics and Pharmacodynamics of 9‐cis‐Retinoic Acid in Healthy Men (Q73556891) (← links)
- Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression (Q73746257) (← links)
- Phase II study of cisplatinum and carboplatinum (CACIS) combination in advanced stage neuroblastomas (Q73883650) (← links)
- Maintained All-Trans Retinoic Acid Therapy in a Patient with Pseudotumour Cerebri Despite Aggravated Symptoms (Q73948537) (← links)
- An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92 (Q74455093) (← links)